• News

The immune system strikes back

Copenhagen, Denmark – November 9, 2016:  Professor Mads Hald Andersen, CSO of IO Biotech and Director of CCIT (Center for Cancer Immune Therapy) at University of Copenhagen Herlev Hospital in Denmark, will be speaking at the SITC Conference in Maryland this week.

Continue Reading

IO Biotech appoints Dr Peter Hirth as Chairman of the Board

Copenhagen, Denmark – October 4, 2016: IO Biotech today announced that industry veteran Dr Peter Hirth will succeed Dr Hans Schambye as Chairman of the Board of Directors. IO Biotech develops novel therapeutic immuno-oncology vaccines targeting immune check point inhibitory targets to treat cancer.

Continue Reading

Positive results from Immunoscore® study presented at ASCO 2016

Dr Jérôme Galon, Research Director at Inserm, Head of the laboratory of Integrative Cancer Immunology, Paris, France, and Scientific Advisor of IO Biotech presented at ASCO 2016 the very positive results of the international initiative, the Immunoscore® study. The assay was developed to predict the ability of a person’s immune system to fight tumor cells and its performance has already been documented in a number of studies for its ability to predict recurrence in colon cancer.

Continue Reading